Visceral obesity in hemodialysis patients


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper considers diagnostic methods for obesity and discusses its different phenotypes in patients with Stage V chronic kidney disease who are treated with programmed hemodialysis.

Full Text

Restricted Access

About the authors

P. Filinyuk

Saint Petersburg State University

A. Rumyantsev

Saint Petersburg State University; Acad. I.P. Pavlov First Saint Petersburg State Medical University

A. Yakovenko

Acad. I.P. Pavlov First Saint Petersburg State Medical University

References

  1. Недогода С.В., Барыкина И.Н., Саласюк А.С. Национальные клинические рекомендации по ожирению: концепция и перспективы // Вестн/ ВолГМУ. - 2017; 61 (1): 134-40
  2. Жернакова Ю.В., Железнова Е.А., Чазова И.Е. и др. Распространенность абдоминального ожирения в субъектах Российской Федерации и его связь с социально-экономическим статусом, результаты эпидемиологического исследования ЭССЕ-РФ // Тер. арх. - 2018; 90 (10): 14-22 DOI: 10.26442/ terarkh2018901014-22.
  3. Смирнов А.В., Каюков И.Г., Румянцев А.Ш. Проблема оценки скорости клубочковой фильтрации при ожирении // Нефрология. - 2017; 21 (2): 20-3 doi: 10.24884/1561-6274-2017-2-20-23.
  4. Degoulet P., Legrain M., Reach I. Mortality risk factors in patients treated by chronic hemodialysis // Report of the Diaphane collaborative study. - 1982; 31 (2): 103-10.
  5. Kalantar-Zadeh K., Kopple J., Kilpatrick R. et al. Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population // Am. J. Kidney Dis. - 2005; 46 (3): 489-500. DOI: 10.1053/j. ajkd.2005.05.020.
  6. Antonopoulos A., Tousoulis D. The molecular mechanisms of obesity paradox // Cardiovasc. Res. - 2017; 113 (9): 1074-86. doi: 10.1093/cvr/ cvx106.
  7. Hainer V., Aldhoon-Hainerova I. Obesity paradox does exist // Diabetes Care. - 2013; 36 (Suppl. 2): 276-81. doi: 10.2337/dcS13-2023.
  8. Garvey W., Garber A., Mechanick J. et al. American association of clinical endocrinologists and american college of endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease // Endocr. Pract. - 2014; 20 (9): 977-89. doi: 10.4158/EP14280.PS.
  9. Malik V., Willett W., Hu F. Global obesity: trends, risk factors and policy implications // Nat. Rev. Endocrinol. - 2013; 9 (1): 13-27. ВРАЧ 2'2020
  10. Gayoso-Diz P., Otero-Gonzalez A., Rodriguez-Alvarez M. et al. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study // BMC Endocr. Disord. - 2013; 13: 47. doi: 10.1186/1472-6823-13-47.
  11. Amato M., Giordano C., Galia M. et al. AlkaMeSy Study Group. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk // Diabetes Care. - 2010; 33: 920-2. doi: 10.2337/dc09-1825.
  12. Самойлова Ю.Г., Кудлай Д.А., Подчиненова Д.В. и др. Биоимпедансометрия как метод диагностики висцерального ожирения в педиатрической практике // Молекулярная медицина. - 2019; 17 (6): 26-31 https://doi.org/10.29296/24999490-2019-06-05.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2020 Russkiy Vrach Publishing House